Targets of miR-200c mediate suppression of cell motility and anoikis resistance

[1]  K. Struhl,et al.  Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells. , 2010, Molecular cell.

[2]  F. Slack,et al.  A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk. , 2010, Cancer research.

[3]  Robert A. Weinberg,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[4]  D. Yu,et al.  TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma , 2010, Oncogene.

[5]  Hyunsoo Kim,et al.  Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. , 2010, Cancer research.

[6]  E. Howe,et al.  Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers , 2009, Journal of oncology.

[7]  Jinghe Huang,et al.  articleVascular endothelial growth factor C promotes cervical cancer metastasis via up-regulation and activation of RhoA / ROCK-2 / moesin cascade , 2010 .

[8]  Yang Liu,et al.  An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3' untranslated region confers risk for hepatocellular carcinoma. , 2009, Carcinogenesis.

[9]  Julia Schüler,et al.  The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs , 2009, Nature Cell Biology.

[10]  K. Sossey-Alaoui,et al.  The miR200 Family of MicroRNAs Regulates WAVE3-dependent Cancer Cell Invasion* , 2009, The Journal of Biological Chemistry.

[11]  Amy McKee,et al.  On Trk—The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer Biology , 2009, Clinical Cancer Research.

[12]  A. Puig-Kröger,et al.  Moesin orchestrates cortical polarity of melanoma tumour cells to initiate 3D invasion , 2009, Journal of Cell Science.

[13]  Michael F. Clarke,et al.  Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells , 2009, Cell.

[14]  C. Mayr,et al.  Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells , 2009, Cell.

[15]  J. Bai,et al.  Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion , 2009, British Journal of Cancer.

[16]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[17]  Ji-Ying Song,et al.  A Twist-Snail Axis Critical for TrkB-Induced Epithelial-Mesenchymal Transition-Like Transformation, Anoikis Resistance, and Metastasis , 2009, Molecular and Cellular Biology.

[18]  Andrés J. García,et al.  Focal adhesion kinase modulates cell adhesion strengthening via integrin activation. , 2009, Molecular biology of the cell.

[19]  S. Nordeen,et al.  MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents , 2009, Molecular Cancer Therapeutics.

[20]  B. Rellahan,et al.  Phospholipase C–mediated hydrolysis of PIP2 releases ERM proteins from lymphocyte membrane , 2009, The Journal of cell biology.

[21]  Dan Li,et al.  Fibronectin promotes invasiveness and focal adhesion kinase tyrosine phosphorylation of human colon cancer cell. , 2008, Hepato-gastroenterology.

[22]  A. Bertotti,et al.  Met-driven invasive growth involves transcriptional regulation of Arhgap12 , 2008, Oncogene.

[23]  Robert A. Weinberg,et al.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. , 2008, Developmental cell.

[24]  M. Korpal,et al.  The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional Repressors ZEB1 and ZEB2* , 2008, Journal of Biological Chemistry.

[25]  T. Brabletz,et al.  A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells , 2008, EMBO reports.

[26]  G. Goodall,et al.  The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.

[27]  Sun-Mi Park,et al.  The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. , 2008, Genes & development.

[28]  Ling Liu,et al.  Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer , 2008, Cancer science.

[29]  Reuven Agami,et al.  RNA-Binding Protein Dnd1 Inhibits MicroRNA Access to Target mRNA , 2007, Cell.

[30]  R. Foisner,et al.  The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity , 2007, Oncogene.

[31]  F. Bertucci,et al.  Moesin expression is a marker of basal breast carcinomas , 2007, International journal of cancer.

[32]  C. Heldin,et al.  Signaling networks guiding epithelial–mesenchymal transitions during embryogenesis and cancer progression , 2007, Cancer science.

[33]  S. Spivack,et al.  Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. , 2007, Cancer research.

[34]  D. Peeper,et al.  Critical role for TrkB kinase function in anoikis suppression, tumorigenesis, and metastasis. , 2007, Cancer research.

[35]  Héctor Peinado,et al.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.

[36]  M. Arpin,et al.  ERM proteins in epithelial cell organization and functions. , 2007, Biochimica et biophysica acta.

[37]  J. Tcherkezian,et al.  Current knowledge of the large RhoGAP family of proteins , 2007, Biology of the cell.

[38]  H. Beug,et al.  Molecular requirements for epithelial-mesenchymal transition during tumor progression. , 2005, Current opinion in cell biology.

[39]  G. Berx,et al.  DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells , 2005, Oncogene.

[40]  E. Widmaier,et al.  The Effect of Leptin on Mouse Trophoblast Cell Invasion1 , 2004, Biology of reproduction.

[41]  D. Peeper,et al.  Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB , 2004, Nature.

[42]  A. Rustgi,et al.  ARHGAP8 is a novel member of the RHOGAP family related to ARHGAP1/CDC42GAP/p50RHOGAP: mutation and expression analyses in colorectal and breast cancers. , 2004, Gene.

[43]  H. Kurita,et al.  Clinical Significance of Cellular Distribution of Moesin in Patients with Oral Squamous Cell Carcinoma , 2004, Clinical Cancer Research.

[44]  L. Lim,et al.  ArhGAP15, a novel human RacGAP protein with GTPase binding property 1 , 2003, FEBS letters.

[45]  J. Thiery.  Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[46]  K. Ying,et al.  Cloning and characterization of ARHGAP12, a novel human rhoGAP gene. , 2002, The international journal of biochemistry & cell biology.

[47]  E. Ruoslahti,et al.  Fibronectin and its integrin receptors in cancer. , 1999, Advances in cancer research.

[48]  O. Tulp,et al.  Reduction of Enhanced Mammary Carcinogenesis in LA/N-cp (Corpulent) Rats by Energy Restriction , 1991, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[49]  R. Kodell,et al.  Accelerated appearance of chemically induced mammary carcinomas in obese yellow (Avy/A) (BALB/c X VY) F1 hybrid mice. , 1982, Journal of toxicology and environmental health.

[50]  G. Brecher,et al.  The Effect of Fat-Enriched Diet on the Incidence of Spontaneous Mammary Tumors in Obese Mice 1 , 1979, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.